Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H19N3O2S |
| Molecular Weight | 377.459 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCS(=O)(=O)N(CC1=CN=CC=C1)C2=CC=CC(=C2)C3=CC=C(C=C3)C#N
InChI
InChIKey=HDVYXILCBYGKGU-UHFFFAOYSA-N
InChI=1S/C21H19N3O2S/c1-2-27(25,26)24(16-18-5-4-12-23-15-18)21-7-3-6-20(13-21)19-10-8-17(14-22)9-11-19/h3-13,15H,2,16H2,1H3
| Molecular Formula | C21H19N3O2S |
| Molecular Weight | 377.459 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/15717213
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15717213
CBiPES is a selective positive allosteric modulator of the metabotropic glutamate receptor group II subtype mGluR2. CBiPES attenuated a stress-induced hyperthermia and PCP-induced hyperlocomotor activity in the mouse model.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15717213
Curator's Comment: Known to be CNS penetrant in mice. Human data not available.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q14416 Gene ID: 2912.0 Gene Symbol: GRM2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15717213 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15717213
In the mouse model of stress-induced hyperthermia, CBiPES was administered subcutaneously at 100 mg/kg.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15717213
mGluR2 potentiation was tested in cell lines that expressed each of the eight human mGlu receptor, mGlu1a, mGlu2, mGlu3, mGlu4a, mGlu5a, mGlu6, mGlu7a, or mGlu8a, in an AV-12 (ATCC-CRL9595) cell background that also stably expresses the rat glutamate aspartate transporter (EAAT-1 or GLAST). With the group II and III receptors (mGlu2/3/4/6/7/8), the promiscuous G protein Gα15 was also stably expressed. This allowed receptor activation to stimulate phospholipase C, increasing inositol triphosphate formation, and subsequently a transient rise of intracellular calcium. Quantitation utilized to be determined using a calcium-sensitive dye and a Fluorometric Imaging Plate Reader (FLIPR). Treatment with CBiPES potentiated glutamate-induced increase in intracellular calcium concentration with IC50 of 92.8 nM
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 13:32:53 GMT 2025
by
admin
on
Wed Apr 02 13:32:53 GMT 2025
|
| Record UNII |
TQ25KB5NW9
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
TQ25KB5NW9
Created by
admin on Wed Apr 02 13:32:53 GMT 2025 , Edited by admin on Wed Apr 02 13:32:53 GMT 2025
|
PRIMARY | |||
|
9864510
Created by
admin on Wed Apr 02 13:32:53 GMT 2025 , Edited by admin on Wed Apr 02 13:32:53 GMT 2025
|
PRIMARY | |||
|
CBiPES
Created by
admin on Wed Apr 02 13:32:53 GMT 2025 , Edited by admin on Wed Apr 02 13:32:53 GMT 2025
|
PRIMARY | |||
|
353235-01-5
Created by
admin on Wed Apr 02 13:32:53 GMT 2025 , Edited by admin on Wed Apr 02 13:32:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|